Metagenomi, Inc. Common StockMGXNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank50
3Y CAGR+13.6%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+13.6%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$25.21M-51.8%
2024$52.30M+16.8%
2023$44.76M+160.2%
2022$17.20M+6978.2%
2021$243000.00-